GLENMEDE TRUST CO NA
BankPosition in HALO — Halozyme Therapeutics, Inc.
CIK 314949
PHILADELPHIA, PA
Position in HALO
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$9,482,319
+$1,415,338 QoQ
Shares Held
146,717
+22.4% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 99.14597490406702.ToString("F0")%
Shared 0.ToString("F0")%
None 0.8540250959329867.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $121,614,834 across 47 Biotechnology names. HALO ranks #4 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
523,291 | $49,252,148 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
565,424 | $13,999,896 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,059 | $13,953,104 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
This page
|
146,717 | $9,482,319 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
405,892 | $9,035,155 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,608 | $2,504,195 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,819 | $1,478,181 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
6,716 | $1,135,138 |
All Filings in HALO
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,482,319 | 146,717 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $8,066,981 | 119,866 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $31,843,039 | 499,029 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $23,137,744 | 483,952 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $27,883,377 | 487,131 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $19,784,120 | 377,848 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,139,711 | 372,166 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,371,214 | 334,719 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $13,109,781 | 343,188 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,496,667 | 346,456 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,205,986 | 345,797 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,471,179 | 342,200 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $15,207,042 | 384,599 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $18,972,140 | 431,185 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,079,707 | 478,428 | Shares | Sole | 2022-05-16 | |
| 2020-09-30 | $6,333 | 241 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,994 | 149 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||